Get the Stockscreener App
11.05
5.96%
-0.70
Pre-market:
10.00
-1.05
-9.50%
Meiragtx Holdings Plc stock is traded at $11.05, with a volume of 1.61M.
It is down -5.96% in the last 24 hours and down -25.49% over the past month.
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
See More
Previous Close:
$11.75
Open:
$11.42
24h Volume:
1.61M
Relative Volume:
1.89
Market Cap:
$1.06B
Revenue:
$79.76M
Net Income/Loss:
$-120.53M
P/E Ratio:
-7.4211
EPS:
-1.489
Net Cash Flow:
$3.75M
1W Performance:
-15.33%
1M Performance:
-25.49%
6M Performance:
+49.12%
1Y Performance:
+33.29%
1-Day Range:
$11.00
$11.55
1-Week Range:
$11.00
$13.47
52-Week Range:
$6.62
$15.35
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Name
Meiragtx Holdings Plc
Sector
Industry
Phone
646-860-7985
Address
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
11.05 | 1.06B | 79.76M | -120.53M | 3.75M | -1.489 |
VRTX
Vertex Pharmaceuticals Inc
|
522.38 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
796.02 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
194.82 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
962.22 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
199.86 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Initiated | H.C. Wainwright | Buy |
| Oct-21-25 | Initiated | Raymond James | Strong Buy |
| Jul-31-24 | Resumed | Chardan Capital Markets | Buy |
| Oct-23-20 | Initiated | RBC Capital Mkts | Outperform |
| Sep-15-20 | Resumed | BofA Securities | Buy |
| Sep-03-19 | Initiated | Piper Jaffray | Overweight |
| Feb-27-19 | Reiterated | Chardan Capital Markets | Buy |
| Jul-03-18 | Initiated | Barclays | Overweight |
| Jul-03-18 | Initiated | BofA/Merrill | Buy |
View All
Meiragtx Holdings Plc Stock (MGTX) Latest News
MeiraGTx stock falls 5.96 percent as earnings beat estimates - AD HOC NEWS
Form 4 MeiraGTx Holdings PLC For: 24 September - Investing.com India
Form 4 MeiraGTx Holdings PLC For: 24 September By Investing.com - Investing.com UK
A 100,000-unit share award for MeiraGTx (MGTX) director Alan Sebulsky vests over three years. - Stock Titan
MGTX Initiated Coverage by Goldman Sachs -- Price Target Announced at $16 - GuruFocus
Goldman Sachs Initiates MeiraGTx at Neutral With $16 Price Target - marketscreener.com
Goldman Sachs initiates MeiraGTx stock coverage with neutral rating - Investing.com
Goldman Sachs initiates MeiraGTx stock coverage with neutral rating By Investing.com - Investing.com Canada
Raymond James stays bullish on Meiragtx stock after rival data By Investing.com - Investing.com Nigeria
MeiraGTx Holdings plc Announces Appointment of Alan M. Sebulsky to its Board of Directors - marketscreener.com
MeiraGTx Appoints Healthcare Investor Alan Sebulsky to Board of Directors - citybiz
MeiraGTx Appoints Accomplished Healthcare Portfolio Manager Alan M. Sebulsky to Board of Directors - Investing News Network
MeiraGTx Appoints Veteran Investor Alan Sebulsky to Board - tipranks.com
MeiraGTx appoints Alan M. Sebulsky to its Board as Class I director - TradingView
MeiraGTx appoints Alan Sebulsky to board of directors By Investing.com - Investing.com Canada
An investor who led a team overseeing over $2 billion in drug-company assets joins MeiraGTx's board. - Stock Titan
Wall Street Analysts See a 128.14% Upside in MeiraGTx (MGTX): Can the Stock Really Move This High? - Eastern Progress
MeiraGTx Holdings (MGTX) Stock Analysis: Unveiling A 125% Upside Potential For Investors - DirectorsTalk Interviews
(MGTX) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
MeiraGTx Holdings PLC Share PriceMGTX, RNS News, Articles, Quotes, & Charts - Proactive financial news
Responsive Playbooks and the MGTX Inflection - Stock Traders Daily
Meiragtx Holdings Stock Price Forecast. Should You Buy MGTX? - StockInvest.us
MeiraGTx Holdings (MGTX) Q2 2026 Earnings: Massive EPS Beat Driven by Non-Operating Items, Stock Still SlipsRevenue Per Share - siam.in
MeiraGTx (MGTX) Slips 2.89% to $13.78 as Gene-Therapy Stock Approaches SupportJelly Roll Trade - vinanet.vn
Regencell Bioscience Holdings Ltd (RGC) Peer Comparison – Compare with Others - Value Research
Why MeiraGTx (MGTX) Is Up 7.7% After Swing to Q2 Profitability and New Leadership Hires - simplywall.st
MeiraGTx (MGTX) Earnings Reading: Profit Per Share Falls Below Its Benchmark in the Reported Period; Closing Move - vinanet.vn
MeiraGTx (NASDAQ:MGTX) Clears Minervini Trend Template and High-Growth Momentum Screen - ChartMill
Tocqueville Asset Management L.P. Makes New $1.05 Million Investment in MeiraGTx Holdings PLC $MGTX - MarketBeat
MeiraGTx CEO Alexandria Forbes sells 62,000 shares for $859,320 - Bitget
Meiragtx CEO Forbes sells $859,320 in company stock By Investing.com - Investing.com Australia
Alexandria Forbes Sells 62,000 Shares of MeiraGTx (NASDAQ:MGTX) Stock - MarketBeat
Meiragtx CEO Forbes sells $859,320 in company stock - Investing.com
MeiraGTx (MGTX) holder readies new sale after recent 62K-share cashout - Stock Titan
MeiraGTx (MGTX) CEO sells 62K shares in preset plan at $13.86 - Stock Titan
MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot - vinanet.vn
MeiraGTx (MGTX) Q1 2026 Results: Profit Per Share Falls Below Its Benchmark under the Current Snapshot; Reported Share Move: Shares Move Higher 0.22% on the DayEarnings Turnaround - dars.gov.et
FY2026 EPS Estimates for MeiraGTx Increased by HC Wainwright - MarketBeat
MeiraGTx (MGTX) Jumps 6.7% to $13.52 as Gene Therapy Pipeline Optimism GrowsWeak Sell Signals - vinanet.vn
Johnson & Johnson Takes $89.72 Billion Position in MeiraGTx Holdings PLC $MGTX - MarketBeat
Price-Driven Insight from (MGTX) for Rule-Based Strategy - Stock Traders Daily
Profit Surge and New Leadership Might Change The Case For Investing In MeiraGTx Holdings (MGTX) - simplywall.st
MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat
MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
What Could MeiraGTx Holdings (MGTX) New Hires And Profit Swing Signal? - Yahoo Finance
Rubric Capital discloses 9.83% MeiraGTx (MGTX) position totaling 9.1M shares - Stock Titan
MeiraGTx (NASDAQ:MGTX) Trading 8.4% Higher Following Strong Earnings - MarketBeat
MGTX Maintains by RBC Capital -- Price Target Raised to $27.00 - GuruFocus
MeiraGTx Seen Nearing First Commercial Launches as Key Programs Advance, RBC Says - marketscreener.com
MeiraGTx (NASDAQ:MGTX) Given New $27.00 Price Target at Royal Bank Of Canada - MarketBeat
MeiraGTx (MGTX) Gains 4.42% as Gene Therapy Focus Draws Investor AttentionETF Inflow Streak - vinanet.vn
Meiragtx Holdings Plc Stock (MGTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):